Section 1244 Small Business Stock Loss

IRC § 1244 turns a painful startup loss into an unusually powerful tax deduction — allowing founders and early investors who lose money on qualifying small business stock to deduct up to $50,000 per year ($100,000 on a joint return) as an ordinary loss, offsetting wages, business income, and any other income, rather than being trapped in the capital loss rules that limit deductions against ordinary income to $3,000 per year. The provision was enacted in 1958 to encourage investment in small businesses by softening the blow of failure: whereas a capital loss can only offset $3,000 of ordinary income annually (with the rest carried forward), a § 1244 ordinary loss on the same investment can wipe out tens of thousands of dollars of other income in the year of the loss. The asymmetry is made even more attractive when paired with the § 1202 QSBS exclusion — gains on the same stock may be excluded from tax entirely while losses generate full ordinary deductions, creating a heads-you-win-tails-you-lose structure that strongly favors holding original-issuance stock in qualifying small businesses through to an outcome.

Current Law (2026)

Key Mechanics

Section 1244 converts what would otherwise be a capital loss on small business stock into an ordinary loss — up to $50,000 per year ($100,000 on a joint return). The significance: capital losses are limited to offsetting capital gains plus $3,000/year of ordinary income; § 1244 ordinary losses reduce wages, business income, or any other ordinary income dollar-for-dollar, without the capital loss limitation. Qualifying stock must be: (1) issued by a domestic small business corporation — defined as having received no more than $1,000,000 in total aggregate capital contributions and paid-in surplus when the stock was issued; (2) stock issued for money or property (not services); (3) the corporation must have derived more than 50% of gross receipts from active trade or business (not investment income) during the 5-year period preceding the loss; (4) the corporation must be a C-corporation (not an S-corporation or partnership). Annual limits: the $50,000/$100,000 cap applies per year; losses above the cap are capital losses subject to normal capital loss limitations. Original issue only: § 1244 treatment is available only to the original shareholder — transferees (even a spouse receiving the stock as a gift) cannot claim § 1244 treatment; the ordinary loss treatment is personal to the original investor. Worthlessness vs. sale: the ordinary loss applies when stock is sold at a loss or becomes worthless. The loss equals the basis in the stock minus the amount realized (zero if worthless). Interaction with § 1202 QSBS: many startups qualify for both § 1244 (ordinary loss on failure) and § 1202 (gain exclusion on success); investors in qualifying small businesses can get ordinary loss treatment on the downside and capital gain exclusion on the upside.

Legal Authority

• 26 U.S.C. § 1244(a) — General rule: loss on § 1244 stock treated as ordinary loss (not capital loss) to the extent of the annual limits
• 26 U.S.C. § 1244(b) — Annual limitation: $50,000 per year ($100,000 joint return); excess over the limit is a capital loss
• 26 U.S.C. § 1244(c) — Definition of § 1244 stock: stock issued by a domestic small business corporation; issued for money or property; corporation must meet asset and gross receipts tests
• 26 U.S.C. § 1244(d) — Special rules: loss can only be claimed by the original shareholder — stock transferred to a different taxpayer (even a spouse) loses § 1244 treatment for the recipient
• 26 U.S.C. § 1244 (DB) — Losses on small business stock: if stock was received in exchange for property with a built-in loss, that basis follows the stock and later increases in basis are treated as tied to non-§ 1244 stock; § 1244 losses count as business losses for net operating loss rules; the rule does not apply to trusts or estates; a "small business corporation" for this purpose is one whose total money and property taken in for stock and capital does not exceed $1,000,000 when the stock was issued (non-cash property counted at the company's adjusted basis less any debt)

How It Works

Section 1244 provides ordinary loss treatment — rather than capital loss treatment — when shares in a qualifying small business are sold or become worthless. The distinction matters enormously: capital losses can only offset capital gains plus $3,000 per year of ordinary income, and unused capital losses carry forward (not back) indefinitely. If you lose $200,000 on a failed startup as a capital loss, it takes years of $3,000 annual deductions (against ordinary income) to fully absorb it, assuming you don't have capital gains to offset. As a § 1244 ordinary loss, the same $200,000 reduces your wage income, business income, or any other ordinary income directly — subject only to the $50,000/$100,000 annual cap.

Qualifying as § 1244 stock requires satisfying four tests at the time of issuance:

The corporation must be a domestic corporation — foreign entities don't qualify. The stock must be issued for money or property — shares received for services are excluded (the compensation element is taxed separately under § 83, and the basis rules don't work for § 1244 purposes). The corporation must have been a small business corporation at the time of issuance — total equity capital contributed to the corporation cannot exceed $1,000,000, counting both the current issuance and all previous equity capital contributions. This cap is measured at the time each tranche of stock is issued, so a company that has received $800,000 in prior contributions can issue only $200,000 more in qualifying § 1244 stock before the cap is exceeded. Finally, during the 5 tax years before the loss year (or the corporation's entire existence if shorter), the corporation must have derived more than 50% of its aggregate gross receipts from non-passive sources — operating income, not investment income — confirming the entity was actually running an active business and not a passive investment vehicle.

The original issuance requirement is the most commonly overlooked limitation. Section 1244 treatment is only available to the original recipient of the stock from the corporation. If you buy shares from a departing founder or on a secondary market, those shares are not § 1244 stock for you — even if they were qualifying § 1244 stock for the original holder. Similarly, if you receive § 1244 stock as a gift or inheritance, you can't claim ordinary loss treatment if those shares subsequently become worthless; the benefit was personal to the original shareholder. A partnership or S corporation that holds § 1244 stock does pass through the ordinary loss treatment to individual partners and shareholders who meet the original issuance requirement, but C corporations that hold § 1244 stock cannot themselves claim § 1244 ordinary loss treatment.

Interaction with § 1202 QSBS: The same shares can qualify as both § 1244 stock (for purposes of loss deductions) and § 1202 QSBS (for purposes of gain exclusions), as long as all conditions for each section are met independently. This creates a strongly asymmetric structure: if the startup succeeds, up to $10 million (or 10× basis) of gain may be excluded from federal tax entirely under § 1202; if the startup fails, up to $50,000/$100,000 per year of the loss is a full ordinary deduction rather than a limited capital loss. This combination is particularly valuable for angel investors and founders who hold positions in multiple qualifying startups and may realize both wins and losses in the same or sequential years.

How It Affects You

If you're a startup founder who received founders' stock: Founders' shares in a qualifying small business almost always satisfy the § 1244 requirements — they were issued for money or property (intellectual property, equipment, or a nominal cash payment), the corporation's total equity at the time was well below $1,000,000, and the business generates operating revenue. If the startup ultimately fails, you can deduct up to $50,000 ($100,000 jointly) of your loss as ordinary income each year rather than being stuck absorbing it as a $3,000-per-year capital loss carryforward. On a $250,000 founders' stake that goes to zero, that difference in a 37% bracket is roughly $85,000 in tax value (ordinary loss) versus $1,100 per year (capital loss against ordinary income). You don't need to make any election or filing in advance — § 1244 treatment is automatic for qualifying stock, and you claim it on your return in the year of the loss.

If you're an angel investor or early-stage investor: Every qualifying early-stage investment that you receive as original issuance directly from the corporation is potential § 1244 stock. If you've invested $150,000 in a startup that fails, you can deduct $100,000 as ordinary income in one year (joint filer limit) and $50,000 the next year (or carry the excess as a capital loss). Contrast this with a secondary purchase of the same shares: your loss would be entirely a capital loss. Before investing, verify with the company that total equity capital at the time of your investment is below $1,000,000 (including the amount you're investing) — once a company has crossed that threshold in total equity raised, new shares are no longer § 1244 stock. This means § 1244 status is largely limited to seed and very early Series A rounds.

If you've already taken a capital loss on startup stock: Review whether the shares qualified as § 1244 stock. If they did and you reported the loss as a capital loss, you may be able to file an amended return (Form 1040-X) to reclassify the loss as ordinary, subject to the annual limits. The three-year statute of limitations for amended returns applies. Given the significant difference in tax benefit between ordinary and capital loss treatment, this is worth reviewing with a tax advisor if you had a startup investment go to zero in the past few years.

If you're a tax advisor or CPA: Section 1244 is frequently overlooked in startup failure situations because clients and their advisors focus on the capital loss rules without asking whether the original investment qualified. Document the § 1244 analysis contemporaneously — before or at the time of the investment — so that the necessary facts (total equity capital at issuance, original issuance, money or property consideration) are in the file when the loss is realized. The gross receipts test (>50% from active business income in the prior 5 years) is the most fact-intensive element and sometimes the only real question for early-stage companies that haven't yet generated significant revenue.

State Variations

Section 1244 is a federal provision. State treatment varies:

• Most states that have a personal income tax follow the federal characterization — if the federal loss is ordinary under § 1244, state income tax treatment generally follows.
• California conforms to federal § 1244 treatment, allowing ordinary loss deduction on qualifying small business stock.
• States with flat capital gains tax rates (where ordinary income and capital gains are taxed the same) benefit less from the § 1244 ordinary loss characterization, though the $3,000 capital loss limitation against ordinary income remains a federal distinction even when state rates are uniform.

Implementing Regulations

• 26 CFR 1.1244(a)-1 — Loss on small business stock treated as ordinary loss; conditions for § 1244 treatment
• 26 CFR 1.1244(b)-1 — Annual limitations on ordinary loss; computation of the $50,000/$100,000 limits
• 26 CFR 1.1244(c)-1 — Definition of small business corporation; total equity capital requirement; gross receipts test
• 26 CFR 1.1244(c)-2 — Special rules for § 1244 stock; original issuance requirement; effect of corporate reorganizations

Pending Legislation

Proposals to raise the § 1244 annual ordinary loss limits (unchanged since 1978 at $50,000/$100,000) have been introduced periodically but not enacted. The Small Business Tax Fairness Act and similar bills have proposed increasing the limit to $100,000/$200,000 to adjust for inflation and align with the QSBS gain exclusion expansion under the OBBBA. No changes were enacted as of 2026.

Recent Developments

• OBBBA QSBS expansion reinforces § 1244 value (2025): The One Big Beautiful Bill Act's expansion of the § 1202 QSBS gain exclusion cap from $10 million to $15 million per investor per company makes the § 1244/§ 1202 combination even more asymmetric in the investor's favor. The same stock that could generate $15 million in tax-free gains under QSBS produces ordinary loss deductions if the investment fails.
• Inflation erosion of limits: The $50,000/$100,000 ordinary loss limits were set in 1978 and have never been adjusted for inflation. In 1978 dollars, the limits represented significant early-stage investment sums; in 2026 dollars, they cover only a fraction of a typical angel round. The practical effect is that § 1244 provides meaningful but incomplete relief for investors with larger positions — losses above the ordinary loss cap revert to capital loss treatment.
• Coordination with net operating losses: § 1244 ordinary losses flow through to the taxpayer's return and can create or increase a net operating loss (NOL). Post-TCJA, NOLs are limited to 80% of taxable income per year and cannot be carried back (with narrow exceptions). The § 1244 loss itself is uncapped as a deduction in the year of the loss subject to the $50,000/$100,000 annual limit — the NOL rules apply to any excess that creates a net loss position.